Join the R&D Postdoctoral Challenge

We're seeking outstanding research proposals to accelerate scientific discovery

Every now and then, New Scientist helps a carefully selected commercial partner speak to our audience. Their support helps us produce the high quality journalism we bring you every week. We hope you find today's message relevant and useful. Submit a proposal and help drive innovative science The R&D Postdoctoral Challenge invites outstanding final year MD and/or PhD students and Postdoctoral Researchers to propose their own innovative ideas that could help transform the treatment of some of the world’s most complex diseases. Candidates must be keen to undertake pioneering R&D focused on preventing, modifying, and potentially curing disease, proposing innovative ideas that align with our therapy areas – oncology, cardiovascular, renal & metabolic diseases, respiratory & immunology, rare disease – and/or our transformative science themes: Enhancing our understanding of disease biology Creating the next generation of therapeutics Better predicting clinical success Pioneering new approaches to engagement in the clinic and beyond Successful candidates will be awarded a fully funded postdoctoral position, joining our vibrant scientific community, with access to expertise, compounds, novel tools and technologies, and the mentoring support they need to turn their ideas into reality. They will access a world of learning opportunities, building the foundations of their professional networks that could last a lifetime. If you’re passionate about working at the pinnacle of scientific discovery, and ready to translate your ideas into meaningful benefit for patients, find out more at: http://www.openinnovation.astrazeneca.com/ Entries close 26th May 2022   * This email has been sent to submitpostforlive@gmail.com * Unsubscribe from further emails relating to selected third party partners from New Scientist. * Read our privacy policy Contact Us   Disclaimer This message is intended only for the use of the person(s) ("Intended Recipient") to whom it is addressed. It may contain information which is privileged and confidential. Accordingly any dissemination, distribution, copying or other use of this message or any of its content by any person other than the Intended Recipient may constitute a breach of civil or criminal law and is strictly prohibited. If you are not the Intended Recipient, please contact the sender as soon as possible.   We and our third party service providers may use cookies and other web technologies in conjunction with this email. These technologies are used to understand activity with this email and on certain portions of our website. This enables us to improve our site, your experience on our site, and the offerings that we may provide to you. If you do not want these technologies placed on your device, please opt-out of receiving emails from us. Copyright New Scientist Registered Office: New Scientist, Northcliffe House, 2 Derry Street, Kensington, London, W8 5TT Registered in England under Company No. 10644366 Australian mailing address: PO Box 2315, Strawberry Hills, NSW 2012, Australia Registered in Australia under ABN 22 621 413 170